Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Anagenics ( (AU:AN1) ) has provided an announcement.
Anagenics Limited announced a change in the director’s interest, with Alexander Beard acquiring an additional 55,564 fully paid ordinary shares through an on-market purchase. This acquisition reflects a slight increase in Beard’s indirect shareholding, indicating a potential vote of confidence in the company’s future prospects and stability.
More about Anagenics
Anagenics Limited operates in the biotechnology industry, focusing on the development and commercialization of innovative health and wellness products. The company is primarily involved in producing and marketing products that cater to consumer health needs.
Current Market Cap: A$2.98M
Learn more about AN1 stock on TipRanks’ Stock Analysis page.